Referral Center Experience With Nonpalpable Contraceptive Implant Removals
Open Access
- 1 October 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 134 (4) , 801-806
Abstract
OBJECTIVE: To describe our experience with office removal of nonpalpable contraceptive implants at our referral center. METHODS: We performed a retrospective cohort study by reviewing the charts of patients referred to our family planning specialty center for nonpalpable or complex contraceptive implant removal from January 2015 through December 2018. We localized nonpalpable implants using high-frequency ultrasonography and skin mapping in radiology, followed by attempted removal in the office using local anesthesia and a modified vasectomy clamp. We abstracted information on demographics, implant location, and outcomes. RESULTS: Of 61 referrals, 55 patients attended their scheduled appointments. Seven patients had palpable implants; six elected removal. The other 48 patients had ultrasound localization, which identified 47 (98%) of the implants; the remaining patient had successful localization with computed tomography imaging. Nonpalpable implants were suprafascial (n=22), subfascial (n=25) and intrafascial (n=1); four of these patients opted to delay removal. Of 50 attempted office removals, all palpable (n=6), all nonpalpable suprafascial (n=21 [100%, 95% CI 83–100%]), and 19 out of 23 (83%, 95% CI 67–98%) subfascial implants were successful. Three of the four patients with failed subfascial implant office removal had successful operating room removal with a collaborative orthopedic surgeon; the other patient sought removal elsewhere. Transient postprocedure neuropathic complaints were noted in 7 out of 23 (30%, 95% CI 12–49%) subfascial and 1 out of 21 (5%, 95% CI 0–13%) suprafascial removals (P=.048). Nonpalpable implants were more likely to be subfascial in nonobese patients (24/34, 71%) as compared with obese (1/13, 8%) patients (P<.001). Seven (28%) of the 25 subfascially located implants had been inserted during a removal–reinsertion procedure through the same incision. CONCLUSION: Most nonpalpable contraceptive implants can be removed in the office by an experienced subspecialty health care provider after ultrasound localization. Some patients may experience transient postprocedure neuropathic pain. Nonpalpable implants in thinner women are more likely to be in a subfascial location.Keywords
This publication has 20 references indexed in Scilit:
- Removal of a Nonpalpable Etonogestrel Implant With Preprocedure Ultrasonography and Modified Vasectomy ClampObstetrics & Gynecology, 2015
- Hormone-releasing contraceptive implants: our experience of complex removals using preoperative ultrasoundContraception, 2015
- Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine systemContraception, 2015
- Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine DevicesContraception, 2015
- Removal of a Nexplanon® implant located in the biceps muscle using a combination of ultrasound and fluoroscopy guidanceContraception, 2014
- Detection and Localization of a Nonpalpable Subdermal Contraceptive Implant Using Ultrasonography: A Case ReportJournal of Medical Ultrasound, 2012
- UK provision for removal of non-palpable contraceptive implantsBMJ Sexual & Reproductive Health, 2009
- Removal of non-palpable etonogestrel implantsBMJ Sexual & Reproductive Health, 2008
- Location and removal of non-palpable Implanon® implants with the aid of ultrasound guidanceBMJ Sexual & Reproductive Health, 2006
- Management and localization strategies for the nonpalpable Implanon rodContraception, 2006